The Cooper Companies, Inc.
NASDAQ:COOMedical - Instruments & Supplies
-$2.30 today
- Market cap
- $11.55B
- Beta
- 0.87
- P/E (TTM)
- 53.8
- EPS (TTM)
- $1.21
Volume 2.20M
Average 2.55M
COO Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
The Cooper Companies, Inc.NASDAQ: COO
Capital Expenditures · Q3 FY2026 · quarter ended Jul 2026
Capital expenditures declines year over year
Q3 FY2026 capital expenditures of $68.7M (cash outflow) fell 29.1% year over year, behind the -12.1% change in trailing-twelve-month capital expenditures. Sequentially, it fell 20.5% from the prior quarter. Over 3 fiscal years it compounded at +14.4% a year.
Context
- Capital expenditures amounted to 8.9% of revenue in FY2025, down 2.0 pp from a year earlier.
- Capital expenditures grew in size in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -29.1% toward the trailing-twelve-month pace of -12.1%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
USD · from the cash flow
- Latest · FY2025
- (362.4M) USD
- Year-over-year change
- +14.0%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2025-10-31 | (362.4M) | +14.0% |
| FY2024 | 2024-10-31 | (421.2M) | -7.3% |
| FY2023 | 2023-10-31 | (392.5M) | -62.2% |
| FY2022 | 2022-10-31 | (242M) | -12.9% |
| FY2021 | 2021-10-31 | (214.4M) | — |
Capital Expenditures vs competitors
How COO compares with its peers on the latest reported figures
- COO's LTM Jul 2026 capital expenditures of $355.3M is the 2nd largest of the 6 companies compared; the peer median is $11.25M.
- Its year-over-year change of -12.1% is the 5th highest of 6, against a peer median of -0.1%.
- Capital expenditures amounts to 8.4% of revenue for COO, versus a peer median of 1.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $582.3M | -0.1% | -3.8% | 5.3% | |
| LTM Jul 2026 | $355.3M | -12.1% | +14.4% | 8.4% | |
| LTM Jun 2026 | $318.06M | -9.4% | +25.9% | 6.0% | |
| LTM Jun 2026 | $11.25M | +78.5% | -36.7% | 1.8% | |
| LTM Apr 2026 | $4.8M | +140.8% | -31.5% | 1.7% | |
| LTM Mar 2026 | $77K | -45.8% | -10.3% | 0.1% | |
| Peer median (excluding COO) | $11.25M | -0.1% | -10.3% | 1.8% | |
Competitors are the stored peer set for COO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Oct 2021 | FY2022 Oct 2022 | FY2023 Oct 2023 | FY2024 Oct 2024 | FY2025 Oct 2025 |
|---|---|---|---|---|---|
| Net Income | 2.94B | 385.8M | 294.2M | 392.3M | 374.9M |
| Depreciation & Amortization | 309.3M | 346.1M | 367.7M | 375.1M | 423M |
| Deferred Income Tax | (2.5B) | 53.9M | 44.7M | 118.9M | 135.2M |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 |
| Change in Working Capital | (149.9M) | (174M) | (218.8M) | (333.7M) | (284.8M) |
| Accounts Receivables | (75.5M) | (33.8M) | (60.2M) | (117.1M) | (120.3M) |
| Inventory | (9.2M) | (40.4M) | (105.4M) | (59.3M) | (46M) |
| Accounts Payables | (16M) | 49.9M | 5.5M | 9.3M | 8M |
| Other Working Capital | (49.2M) | (149.7M) | (58.7M) | (166.6M) | (126.5M) |
| Other Non-Cash Items | 136.7M | 80.6M | 119.7M | 156.7M | 147.8M |
| Operating Cash Flow | 738.6M | 692.4M | 607.5M | 709.3M | 796.1M |
| Capital Expenditures | (214.4M) | (242M) | (392.5M) | (421.2M) | (362.4M) |
| Acquisitions (Net) | 0 | (1.59B) | (56.5M) | (343.4M) | (10.5M) |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (235.9M) | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (450.3M) | (1.83B) | (449M) | (764.6M) | (372.9M) |
| Debt Repayment | (309.9M) | 1.28B | (180.8M) | 5.6M | (79.9M) |
| Common Stock Issued | 26.3M | 16.1M | 23M | 63.9M | 16M |
| Common Stock Repurchased | (24.8M) | (78.5M) | 0 | 0 | (290.1M) |
| Dividends Paid | (3M) | (3M) | (3M) | 0 | 0 |
| Other Financing Activities | 0 | (19.7M) | (13.1M) | (30.3M) | (71.9M) |
| Financing Cash Flow | (311.4M) | 1.19B | (173.9M) | 39.2M | (425.9M) |
| Effect of Forex Changes | 2.6M | (12.6M) | (2.3M) | 2.9M | 5.6M |
| Net Change in Cash | (20.5M) | 42.3M | (17.7M) | (13.2M) | 2.9M |
| Free Cash Flow | 524.2M | 450.4M | 215M | 288.1M | 433.7M |
The Cooper Companies, Inc.
NASDAQ:COO
Intrinsic Alpha fair value
Locked
Current Price
$60.75
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.